Henry Schein stock trades at USD 85.56 after Q2 guidance

Henry Schein stock was trading at USD 85.56 on Nasdaq on September 24, 2026, at 3:26 p.m. ET, up 0.60 percent during the session. The healthcare distributor also carries a fresh financing update, with its revolving credit facility expanded to USD 1.25 billion from USD 1 billion.

Credit line reaches USD 1.25 billion

According to Simply Wall St on September 24, 2026, Henry Schein amended and restated its revolving credit agreement. Total commitments rose from USD 1 billion to USD 1.25 billion, while the facility maturity moved to September 19, 2031.

The financing change gives Henry Schein additional capacity for working capital, capital spending, share repurchases, refinancing, and acquisitions, according to the same September 24, 2026 report. For investors, the key comparison is not only the larger amount but also the five-year extension of the facility term.

Q2 sales rose 6.7 percent

Henry Schein generated USD 3.46 billion in global sales in Q2 2026, up 6.7 percent from Q2 2025, according to Yahoo Finance. GAAP diluted EPS was USD 0.82, while non-GAAP diluted EPS reached USD 1.27, an increase of 15.5 percent from the prior-year quarter.

The earnings mix matters because the adjusted figure grew faster than sales. Management expects fiscal 2026 non-GAAP diluted EPS of USD 5.29 to USD 5.39, representing growth of 6 percent to 8 percent against 2025 non-GAAP diluted EPS of USD 4.97.

Stock remains below yearly high

At USD 85.56 on September 24, 2026, Henry Schein stock stood 7.18 percent below its 52-week high of USD 92.18 and above its 52-week low of USD 61.95. The market capitalization was USD 9,746,829,654 on the same date, putting the financing expansion alongside a company-specific earnings comparison.